New Zealand Expert Calls U.S. Drug Proposal For Free Trade Agreement 'Dangerous'
This article was originally published in PharmAsia News
Executive Summary
The proposed nine-nation Trans-Pacific Partnership Agreement contains U.S. proposals that would allow drug makers to more easily challenge reimbursement decisions by New Zealand's Pharmac, opponents say